Effectiveness of Ormeloxifene versus Norethisterone acetate for control of bleeding in women with abnormal uterine bleeding– A randomized control trial.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- endometrial thickness, blood loss in terms of PBAC
研究概览
简要总结
This study is a randomized trial to compare the efficacy of ormeloxifene and norethisterone acetate in women with abnormal uterine bleeding. •The women will randomly be allocated to 2 groups of 30 each. Group O will be given Ormeloxifene tablet 60mg stat and Group N will be given Tab norethisterone acetate 5mg 2tab TDS. We will see for control of bleeding in both the group. If in any group bleeding is not controlled we will give tranexamic acid injectable or oral. After active bleeding controlled we will give in Group O tab Ormeloxifene 60mg twice a week for 12 weeks followed by 60mg once a week for next 12 weeks. Group N will be given Norethisterone acetate tablet 5mg twice a day for 21 days for 6 cycles. Follow up will be done at 1, 3, 6 months. At each visit a detailed menstrual history will be taken, PBAC score will be calculated. •The primary outcome measures will be reduction in amount of menstrual blood loss (assessed by fall in PBAC score and patient’s subjective assessment),hemoglobin concentration and decrease in endometrial thickness in proliferative phase on transvaginal ultrasound.Secondary outcome measures will be the side effect which will be assessed at 1month revisit.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 21.00 Year(s) 至 47.00 Year(s)(—)
- 性别
- Female
入选标准
- •women willing to keep record of vaginal bleeding and regular follow up.
排除标准
- •PCOS, postmenopausal bleeding, heart disease, genital malignancy, puberty menorrhagia.
结局指标
主要结局
endometrial thickness, blood loss in terms of PBAC
时间窗: 1month, 3month, 6month
次要结局
- oligomenorrhea, hypomenrrhea, weight gain, nausea, vomiting(1month)
研究者
Vasundhara Wasudeo Gawande
Nkp Salve Institute Of Medical Sciences And Research Centre,Nagpur
